本報告已在2012年03月01日停止出版。
更改為出版
Global Genetic Testing Market Analysis
出版日期 : 2012年01月
商品編碼: 228186
全球遺傳基因檢驗市場在2010年為15億美金，佔全分子診斷市場的15%。該市場預計在2012∼2015年將以年率26%擴大，並將達到40億美金。新生兒篩檢的需求增加及老年痴呆症、乳癌、大腸癌、糖尿病等發病率高漲，是推動該市場成長的主因。
本報告提供全球遺傳基因檢驗市場相關整體分析，彙整目前的市場規模與產品上市，各種疾病，各地區趨勢，策略性收購趨勢等資料，加上參與企業的競爭簡介等，為您概述為以下內容。
第1章 分析師的觀點
第2章 調查方法
第3章 遺傳基因檢驗的簡介
第4章 全球遺傳基因檢驗市場概要
第5章 不同疾病分析
第6章 各國分析
第7章 產業發展
第8章 法律制度
第9章 競爭評估
- Abbott Laboratories
- Qiagen N.V.
- bioMerieux SA
- Hoffmann-La Roche Ltd
- Quest Diagnostics
- Myriad Genetics
圖表
Abstract
In a rapidly growing molecular diagnostics market, genetic testing represents
a highly attractive segment. Genetic testing is a form of medical test that
recognizes alteration in chromosomes, genes, or proteins. Most of the time,
testing is used to find changes that are associated with inherited disorders.
The results of a genetic test can confirm or rule out a suspected genetic
condition or help determine a person' s chance of developing or passing on a
genetic disorder. Several hundred genetic tests are currently in use, and more
are being developed.
With the significant increase in the number of available tests, the genetic
testing market is witnessing a strong growth pattern. According to our latest
report, "Global Genetic Testing Market Analysis", the global genetic testing
sector was worth around US$ 1.5 Billion in 2010 that corresponds to a share of
approximately 15% in the total molecular diagnostics market. The market is
further likely to grow at the rate of around 26% during 2012-2015 to reach
around US$ 4 Billion. Factors contributing to this growth include increasing
demand of newborn screening, high incidences of Alzheimer disease, breast
cancer, colorectal cancer, diabetes etc, and research innovations.
Controversies over the splendid growth of DTC genetic testing have attracted
lots of opinions and views on the selling of DNA-based tests directly to
consumers. With the FDA intervention, the subject has become of more
significance and it would be interesting to see whether new regulations do
come in or not. The report, in this context, has presented an effective
insight on the current developments in DTC genetic tests.
The report "Global Genetic Testing Market Analysis", covers almost all aspects
of the global genetic testing market and provides reliable statistics on
current market size and other areas. The report focuses on key regions to
illustrate the state of genetic testing market & developments as these
countries are witnessing improved private sector activities. Moreover, the
availability of gene tests for key diseases has been discussed in a prudent
manner. Recent developments with respect to product launches and strategic
acquisitions have also been covered. Overall, the report is meant to provide a
worth insight into the genetic testing market that would help the client to
get acquainted with all the necessary information.
Table of Contents
1. Analyst View
2. Research Methodology
3. Introduction to Genetic Testing
4. Global Genetic Testing Market Overview
- 4.1 Market Outlook
- 4.2 DTC Genetic Testing
5. Disease Wise Analysis
- 5.1 Alzheimer' s Disease
- 5.2 Cystic Fibrosis
- 5.3 Cancer
6. Country Level Analysis
- 6.1 US
- 6.2 Europe
- 6.3 Japan
- 6.4 Korea
7. Industry Developments
- 7.1 Key Product Launches
- 7.2 Key Strategic Acquisitions & Agreements
8. Regulatory Landscape
9. Competitive Assessment
- 9.1 Abbott Laboratories
- 9.2 Qiagen N.V.
- 9.3 bioMerieux SA
- 9.4 Hoffmann-La Roche Ltd
- 9.5 Quest Diagnostics
- 9.6 Myriad Genetics
List of Figures:
- Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011
- Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011
- Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$),
2012-2015
- Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015
- Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment
(2007-2010)
- Figure 4-6: Number of DTC Genetic Testing Companies by Country
- Figure 6-1: Number of Laboratories and Diseases for Genetic Testing
(1993-2010)
- Figure 6-2: US - Share of Diagnostics Testing in Healthcare Spending
- Figure 6-3: Europe - EQA Scheme Participation by Country (Number), 2010
- Figure 9-1: Quest Diagnostics - Sales by Testing (%), 2010
- Figure 9-2: Myriad Genetics - Sales by Products (%), 2011
List of Tables:
- Table 4-1: Key Companies in DTC Genetic Testing Segment
- Table 5-1: Test Availability and Market Size for Key Conditions (2008)
- Table 6-1: US - FDA Approved Pharmacogenetic Tests
- Table 6-2: EU - Key Indicators in Genetics Market
- Table 6-3: Europe - Recognized Accreditation Bodies in Key Countries
- Table 8-1: US - Key Elements for Genetic Testing Regulation
- Table 8-2: EU - Genetic Testing Regulation in Key Countries
